Trial Profile
Safety and efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffolds
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 26 Dec 2015 New trial record